Study never started due to COVID-19 pandemic

Subjects in this study will wear the VitalPatch with the added ECG Interpretation and arrhythmia detection features which will expedite the identification of patients whose condition may rapidly deteriorate as well as eliminate the majority of non-actionable alarms.

This project intends to validate, through comparative study, the output of new technologies (ECG Interpretation and arrhythmia detection) to the VistaCenter platform, aiming to replace current telemetry monitoring equipment. The new technology, through the previous Mercy pilot study, has demonstrated greater accuracy in the detection of ventricular tachycardia patterns and other dysrhythmias/arrhythmias, as well as, reducing the volume of false alarms resulting in the mitigation of alarm fatigue experienced by bedside staff and monitor technicians.

Inclusion Criteria:

• Age ≥ 18 years old,
• No skin trauma to the site where the patch will be applied
• No known allergies to hydrocolloid or silicone based adhesives
• Admitted to Mercy Hospital Washington Cardiac Unit on the 5th floor and have been placed in one of the assigned rooms and require cardiac/telemetry monitoring as ordered by their physician

Exclusion Criteria:

• Pacemaker or Implanted Defibrillator (ICD)
• Pregnancy
• Adults unable to provide informed consent
• Individuals who cannot read and understand English
• Prisoners
• Not recommended for use in MRI